Related references
Note: Only part of the references are listed.A Rationally Designed Semiconducting Polymer Brush for NIR-II Imaging-Guided Light-Triggered Remote Control of CRISPR/Cas9 Genome Editing
Ling Li et al.
ADVANCED MATERIALS (2019)
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
Frans V. Suurs et al.
PHARMACOLOGY & THERAPEUTICS (2019)
A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing
Chongyi Liu et al.
SCIENCE ADVANCES (2019)
Strategies of Combination Drug Delivery for Immune Checkpoint Blockades
Huitong Ruan et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
Ying-Li Luo et al.
ACS NANO (2018)
Thermo-triggered Release of CRISPR-Cas9 System by Lipid-Encapsulated Gold Nanoparticles for Tumor Therapy
Peng Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing
Wenhua Zhou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Active Intracellular Delivery of a Cas9/sgRNA Complex Using Ultrasound-Propelled Nanomotors
Malthe Hansen-Bruhn et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice
Ling Li et al.
ACS NANO (2017)
Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression
Kyle J. Isaacson et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Padmanee Sharma et al.
LANCET ONCOLOGY (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
J. M. Michot et al.
EUROPEAN JOURNAL OF CANCER (2016)
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Christophe Massard et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing
Wujin Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Fluorinated poly(propylenimine) dendrimers as gene vectors
Hongmei Liu et al.
BIOMATERIALS (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios
Mingming Wang et al.
NATURE COMMUNICATIONS (2014)
Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake
Heather Herd et al.
ACS NANO (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica Nanoparticles
Limin Pan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems
Eisaku Kondo et al.
NATURE COMMUNICATIONS (2012)
Programmed cell removal: a new obstacle in the road to developing cancer
Mark P. Chao et al.
NATURE REVIEWS CANCER (2012)
Polymer-Coated NaYF4:Yb3+, Er3+ Upconversion Nanoparticles for Charge-Dependent Cellular Imaging
Jiefu Jin et al.
ACS NANO (2011)
Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
Evan J. Lipson et al.
CLINICAL CANCER RESEARCH (2011)
Hyaluronan-CD44 interactions as potential targets for cancer therapy
Suniti Misra et al.
FEBS JOURNAL (2011)
Curcumin-Loaded Lipid and Polymeric Nanocapsules Stabilized by Nonionic Surfactants: An In Vitro and In Vivo Antitumor Activity on B16-F10 Melanoma and Macrophage Uptake Comparative Study
Leticia Mazzarino et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2011)
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Josiane E. Garneau et al.
NATURE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9
Adekunle I. Elegbede et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Design and development of polymers for gene delivery
DW Pack et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)
Share Paper
